PIONEER 5 and 8 also showed efficacy and safety of oral semaglutide as a second- and third-line drug.[15,16,17,18,19,20,21,22,30,31] Thus, oral semaglutide can be used across the spectrum of diabetes as a first-, second- and third-line drug
Your stomach protests louder
Dosing: Tirzepatide's therapeutic doses (515 mg/week) are significantly higher by mass than semaglutide (0.252.4 mg/week), requiring more active ingredient per vial
Set up your monitoring in advance: a weight trend, waist measurement, and one simple strength metric you can repeat consistently
For most researchers, the dual AOD 9604 plus tirzepatide combination provides sufficient metabolic coverage without the risks of more complex stacks
Starting at the lowest possible dose and increasing slowly gives your body time to adjust